Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1

Status

Active not recruiting 18 Recruiting 14 Completed 9 Terminated 6 Withdrawn 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1

Interventions

Cisplatin 267 Oxaliplatin 194 Carboplatin 189 Capecitabine 183 Docetaxel 176 apatinib 164 Paclitaxel 158 Bevacizumab 155 Gemcitabine 154 Radiotherapy 146 camrelizumab 145 Fluorouracil 144 Cyclophosphamide 123 Irinotecan 119 Drug Therapy 118 sintilimab 107 Etoposide 99 anlotinib 90 S 1 (combination) 88 Leucovorin 85 pembrolizumab 82 Pemetrexed 78 Doxorubicin 77 toripalimab 76 tislelizumab 75 Dexamethasone 70 Trastuzumab 65 Neoadjuvant Therapy 64 Rituximab 62 Cetuximab 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × deltacortene × Clear all

NCT00795613 2015-10-19

HD0607

Ospedale Santa Croce-Carle Cuneo

Phase 2 Unknown

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡